drugset / Trial / NCT01423721

Relative Bioavailability of Bromhexine Given as Granules and Syrup in Healthy Volunteers (Clinical Phase I Study)

NCT01423721 ↗

Phase 1 Completed 39 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the current study is to investigate relative bioavailability of bromhexine hydrochloride given as granules and syrup

Timeline

Start
2011-08
Primary completion
2011-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromihexine Unknown 16 mg Oral

Indications

No indication recorded.